The global Early Diagnosis Kit for Alzheimer's Disease market was valued at US$ 113.85 million in 2023 and is anticipated to reach US$ 201.37 million by 2030, witnessing a CAGR of 8.33% during the forecast period 2024-2030.
North American market for Early Diagnosis Kit for Alzheimer's Disease is estimated to increase from $ 33.39 million in 2023 to reach $ 60.80 million by 2030, at a CAGR of 8.65% during the forecast period of 2024 through 2030.
Asia-Pacific market for Early Diagnosis Kit for Alzheimer's Disease is estimated to increase from $ 40.18 million in 2023 to reach $ 79.16 million by 2030, at a CAGR of 10.01% during the forecast period of 2024 through 2030.
The major global manufacturers of Early Diagnosis Kit for Alzheimer's Disease include Roche Diagnostics Fujirebio, Quanterix and Revvity etc. In 2023, the world's top three vendors accounted for approximately 57.06% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Diagnosis Kit for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Diagnosis Kit for Alzheimer's Disease.
The Early Diagnosis Kit for Alzheimer's Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Early Diagnosis Kit for Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Diagnosis Kit for Alzheimer's Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Roche Diagnostics
- Fujirebio
- Quanterix
- Revvity
- People Bio
- Easund Bio-tech and Pharmakea
- MagQu
- Solgent
- Sysmex
- Fujifilm
- Immuno-Biological Laboratories
- Shenzhen Anqun Bioengineering
- Amoneta Diagnostics
Segment by Type
- Blood
- CSF (Cerebrospinal Fluid)
- Others (Saliva or Urine)
Segment by Application
Consumption by Region
- North America
- U.S.
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Taiwan
- Southeast Asia
- Rest of APAC
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Middle East
- Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Early Diagnosis Kit for Alzheimer's Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Early Diagnosis Kit for Alzheimer's Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Early Diagnosis Kit for Alzheimer's Disease Market Overview
- 1.1 Product Definition
- 1.2 Early Diagnosis Kit for Alzheimer's Disease by Type
- 1.2.1 Global Early Diagnosis Kit for Alzheimer's Disease Market Value Comparison by Type (2024-2030)
- 1.2.2 Blood
- 1.2.3 CSF
- 1.2.4 Others
- 1.3 Early Diagnosis Kit for Alzheimer's Disease by Application
- 1.4 Global Early Diagnosis Kit for Alzheimer's Disease Market Size Estimates and Forecasts
- 1.4.1 Global Early Diagnosis Kit for Alzheimer's Disease Revenue 2019-2030
- 1.4.2 Global Early Diagnosis Kit for Alzheimer's Disease Sales 2019-2030
- 1.4.3 Global Early Diagnosis Kit for Alzheimer's Disease Market Average Price (2019-2030)
- 1.5 Assumptions and Limitations
2 Early Diagnosis Kit for Alzheimer's Disease Market Competition by Manufacturers
- 2.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales Market Share by Manufacturers (2019-2024)
- 2.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue Market Share by Manufacturers (2019-2024)
- 2.3 Global Early Diagnosis Kit for Alzheimer's Disease Average Price by Manufacturers (2019-2024)
- 2.4 Global Key Players of Early Diagnosis Kit for Alzheimer's Disease, Industry Ranking, 2022 VS 2023 VS 2024
- 2.5 Global Key Manufacturers of Early Diagnosis Kit for Alzheimer's Disease, Manufacturing Sites & Sales Regions
- 2.6 Global Key Manufacturers of Early Diagnosis Kit for Alzheimer's Disease, Product Type & Application
- 2.7 Established Date of Global Early Diagnosis Kit for Alzheimer's Disease Key Manufacturers
- 2.8 Global Early Diagnosis Kit for Alzheimer's Disease Market Competitive Situation and Trends
- 2.8.1 Global Early Diagnosis Kit for Alzheimer's Disease Market Concentration Rate
- 2.8.2 The Global 5 and 10 Largest Early Diagnosis Kit for Alzheimer's Disease Players Market Share by Revenue
- 2.8.3 Global Early Diagnosis Kit for Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Early Diagnosis Kit for Alzheimer's Disease Market Scenario by Region
- 3.1 Global Early Diagnosis Kit for Alzheimer's Disease Market Size by Region: 2019 Versus 2023 Versus 2030
- 3.2 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Region: 2019-2030
- 3.2.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Region: 2019-2024
- 3.2.2 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Region: 2025-2030
- 3.3 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Region: 2019-2030
- 3.3.1 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Region: 2019-2024
- 3.3.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Region: 2025-2030
- 3.4 North America Early Diagnosis Kit for Alzheimer's Disease Market Facts & Figures by Country
- 3.4.1 North America Early Diagnosis Kit for Alzheimer's Disease Market Size by Country: 2019 VS 2023 VS 2030
- 3.4.2 North America Early Diagnosis Kit for Alzheimer's Disease Sales by Country (2019-2030)
- 3.4.3 North America Early Diagnosis Kit for Alzheimer's Disease Revenue by Country (2019-2030)
- 3.4.4 U.S.
- 3.4.5 Canada
- 3.5 Europe Early Diagnosis Kit for Alzheimer's Disease Market Facts & Figures by Country
- 3.5.1 Europe Early Diagnosis Kit for Alzheimer's Disease Market Size by Country: 2019 VS 2023 VS 2030
- 3.5.2 Europe Early Diagnosis Kit for Alzheimer's Disease Sales by Country (2019-2030)
- 3.5.3 Europe Early Diagnosis Kit for Alzheimer's Disease Revenue by Country (2019-2030)
- 3.5.4 Germany
- 3.5.5 France
- 3.5.6 U.K.
- 3.5.7 Italy
- 3.5.8 Russia
- 3.6 Asia Pacific Early Diagnosis Kit for Alzheimer's Disease Market Facts & Figures by Region
- 3.6.1 Asia Pacific Early Diagnosis Kit for Alzheimer's Disease Market Size by Region: 2019 VS 2023 VS 2030
- 3.6.2 Asia Pacific Early Diagnosis Kit for Alzheimer's Disease Sales by Region (2019-2030)
- 3.6.3 Asia Pacific Early Diagnosis Kit for Alzheimer's Disease Revenue by Region (2019-2030)
- 3.6.4 China
- 3.6.5 Japan
- 3.6.6 South Korea
- 3.6.7 India
- 3.6.8 Taiwan
- 3.6.9 Southeast Asia
- 3.7 Latin America Early Diagnosis Kit for Alzheimer's Disease Market Facts & Figures by Country
- 3.7.1 Latin America Early Diagnosis Kit for Alzheimer's Disease Market Size by Country: 2019 VS 2023 VS 2030
- 3.7.2 Latin America Early Diagnosis Kit for Alzheimer's Disease Sales by Country (2019-2030)
- 3.7.3 Latin America Early Diagnosis Kit for Alzheimer's Disease Revenue by Country
- 3.7.4 Mexico
- 3.7.5 Brazil
- 3.8 Middle East and Africa Early Diagnosis Kit for Alzheimer's Disease Market Facts & Figures by Country
- 3.8.1 Middle East and Africa Early Diagnosis Kit for Alzheimer's Disease Market Size by Country: 2019 VS 2023 VS 2030
- 3.8.2 Middle East and Africa Early Diagnosis Kit for Alzheimer's Disease Sales by Country (2019-2030)
- 3.8.3 Middle East and Africa Early Diagnosis Kit for Alzheimer's Disease Revenue by Country
- 3.8.4 Middle East
- 3.8.5 Africa
4 Segment by Type
- 4.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Type (2019-2030)
- 4.1.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Type (2019-2024)
- 4.1.2 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Type (2025-2030)
- 4.1.3 Global Early Diagnosis Kit for Alzheimer's Disease Sales Market Share by Type (2019-2030)
- 4.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Type (2019-2030)
- 4.2.1 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Type (2019-2024)
- 4.2.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Type (2025-2030)
- 4.2.3 Global Early Diagnosis Kit for Alzheimer's Disease Revenue Market Share by Type (2019-2030)
- 4.3 Global Early Diagnosis Kit for Alzheimer's Disease Price by Type (2019-2030)
5 Segment by Application
- 5.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Application (2019-2030)
- 5.1.1 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Application (2019-2024)
- 5.1.2 Global Early Diagnosis Kit for Alzheimer's Disease Sales by Application (2025-2030)
- 5.1.3 Global Early Diagnosis Kit for Alzheimer's Disease Sales Market Share by Application (2019-2030)
- 5.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Application (2019-2030)
- 5.2.1 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Application (2019-2024)
- 5.2.2 Global Early Diagnosis Kit for Alzheimer's Disease Revenue by Application (2025-2030)
- 5.2.3 Global Early Diagnosis Kit for Alzheimer's Disease Revenue Market Share by Application (2019-2030)
- 5.3 Global Early Diagnosis Kit for Alzheimer's Disease Price by Application (2019-2030)
6 Key Companies Profiled
- 6.1 Roche Diagnostics
- 6.1.1 Roche Diagnostics Company Information
- 6.1.2 Roche Diagnostics Description and Business Overview
- 6.1.3 Roche Diagnostics Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.1.4 Roche Diagnostics Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.2 Fujirebio
- 6.2.1 Fujirebio Company Information
- 6.2.2 Fujirebio Description and Business Overview
- 6.2.3 Fujirebio Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.2.4 Fujirebio Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.3 Quanterix
- 6.3.1 Quanterix Company Information
- 6.3.2 Quanterix Description and Business Overview
- 6.3.3 Quanterix Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.3.4 Quanterix Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.4 Revvity
- 6.4.1 Revvity Company Information
- 6.4.2 Revvity Description and Business Overview
- 6.4.3 Revvity Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.4.4 Revvity Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.5 People Bio
- 6.5.1 People Bio Company Information
- 6.5.2 People Bio Description and Business Overview
- 6.5.3 People Bio Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.5.4 People Bio Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.6 Easund Bio-tech and Pharmakea
- 6.6.1 Easund Bio-tech and Pharmakea Company Information
- 6.6.2 Easund Bio-tech and Pharmakea Description and Business Overview
- 6.6.3 Easund Bio-tech and Pharmakea Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.6.4 Easund Bio-tech and Pharmakea Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.7 MagQu
- 6.7.1 MagQu Company Information
- 6.7.2 MagQu Description and Business Overview
- 6.7.3 MagQu Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.7.4 MagQu Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.8 Solgent
- 6.8.1 Solgent Company Information
- 6.8.2 Solgent Description and Business Overview
- 6.8.3 Solgent Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.8.4 Solgent Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.9 Sysmex
- 6.9.1 Sysmex Company Information
- 6.9.2 Sysmex Description and Business Overview
- 6.9.3 Sysmex Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.9.4 Sysmex Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.10 Fujifilm
- 6.10.1 Fujifilm Company Information
- 6.10.2 Fujifilm Description and Business Overview
- 6.10.3 Fujifilm Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.10.4 Fujifilm Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.11 Immuno-Biological Laboratories
- 6.11.1 Immuno-Biological Laboratories Company Information
- 6.11.2 Immuno-Biological Laboratories Description and Business Overview
- 6.11.3 Immuno-Biological Laboratories Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.11.4 Immuno-Biological Laboratories Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.12 Shenzhen Anqun Bioengineering
- 6.12.1 Shenzhen Anqun Bioengineering Company Information
- 6.12.2 Shenzhen Anqun Bioengineering Description and Business Overview
- 6.12.3 Shenzhen Anqun Bioengineering Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.12.4 Shenzhen Anqun Bioengineering Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
- 6.13 Amoneta Diagnostics
- 6.13.1 Amoneta Diagnostics Company Information
- 6.13.2 Amoneta Diagnostics Description and Business Overview
- 6.13.3 Amoneta Diagnostics Early Diagnosis Kit for Alzheimer's Disease Sales, Revenue and Gross Margin (2019-2024)
- 6.13.4 Amoneta Diagnostics Early Diagnosis Kit for Alzheimer's Disease Product Portfolio
7 Industry Chain and Sales Channels Analysis
- 7.1 Early Diagnosis Kit for Alzheimer's Disease Industry Chain Analysis
- 7.2 Early Diagnosis Kit for Alzheimer's Disease Key Raw Materials
- 7.2.1 Key Raw Materials
- 7.2.2 Raw Materials Key Suppliers
- 7.3 Manufacturing Costs Percentage of Early Diagnosis Kit for Alzheimer's Disease
- 7.4 Early Diagnosis Kit for Alzheimer's Disease Sales and Marketing
- 7.5 Early Diagnosis Kit for Alzheimer's Disease Customers
8 Early Diagnosis Kit for Alzheimer's Disease Market Dynamics
- 8.1 Early Diagnosis Kit for Alzheimer's Disease Industry Trends
- 8.2 Early Diagnosis Kit for Alzheimer's Disease Market Drivers
- 8.3 Early Diagnosis Kit for Alzheimer's Disease Market Challenges
- 8.4 Early Diagnosis Kit for Alzheimer's Disease Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.1.1 Research Programs/Design
- 10.1.2 Market Size Estimation
- 10.1.3 Market Breakdown and Data Triangulation
- 10.2 Data Source
- 10.2.1 Secondary Sources
- 10.2.2 Primary Sources
- 10.3 Author List
- 10.4 Disclaimer